Wall Street Lunch: Pfizer Looks To Take Next Step In Weight-Loss Drugs [Seeking Alpha]
Pfizer, Inc. (PFE)
Last pfizer, inc. earnings: 4/28 06:45 am
Check Earnings Report
US:NYSE Investor Relations:
investors.pfizer.com/investors-overview/default.aspx
Company Research
Source: Seeking Alpha
Consumer confidence slightly down in May, with expectations index falling. Tesla recalls thousands of Cybertrucks over wiper defect. Hedge funds selling chip stocks and tech, while net buying financials. Listen below or on the go on Apple Podcasts and Spotify Weight loss drug candidate will differ from popular GLP-1s. (0:16) Tesla recalls thousands of Cybertrucks Hedge funds keep cashing in on tech. (3:55) The following is an abridged transcript: Our top story so far, Pfizer ( NYSE: PFE ) CEO Albert Bourla said the drugmaker is testing three new weight loss drugs, one of which will have a different mechanism from currently available and popular GLP-1 agonists. Bourla did not reveal the exact mechanism of the third drug, but mentioned the other two would be GLP-1 candidates similar to Novo Nordisk's ( NVO ) Wegovy, which recently received approval in China. The chief executive also said Pfizer plans to release data later in 2024 showing progress in development of one o
Show less
Read more
Impact Snapshot
Event Time:
PFE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PFE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PFE alerts
High impacting Pfizer, Inc. news events
Weekly update
A roundup of the hottest topics
PFE
News
- What to know about the XEC Covid variant gaining traction in the U.S. [MSNBC.com]MSNBC.com
- Tax Cuts - An Examination Of The 2017 TCJA Impact [zero hedge]zero hedge
- What to know about the XEC Covid variant [MSNBC.com]MSNBC.com
- Agios cut at Leerink on overhang from Pfizer's Oxbryta withdrawal [Seeking Alpha]Seeking Alpha
- Biopharmaceutical Market Size Projected to Reach USD 17,902.42 Billion by 2032 with 49.60% CAGR – SNS Insider [Yahoo! Finance]Yahoo! Finance
PFE
Earnings
- 7/30/24 - Beat
PFE
Sec Filings
- 9/16/24 - Form 4
- 9/16/24 - Form 4
- 9/16/24 - Form 4
- PFE's page on the SEC website